Condensed Statement of Shareholders' Deficiency - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance	$ (784,647)	$ (694,402)	$ (743,420)	$ (655,736)
Net loss	(19,938)	(20,552)	(61,165)	(59,218)
Ending Balance	$ (804,585)	$ (714,954)	$ (804,585)	$ (714,954)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Beginning Balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Ending Balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Ending Balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance	8,418,684	8,418,684	8,418,684	8,418,684
Ending Balance	8,418,684	8,418,684	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning Balance	(9,205,231)	(9,114,986)	(9,164,004)	(9,076,320)
Net loss	(19,938)	(20,552)	(61,165)	(59,218)
Ending Balance	$ (9,225,169)	$ (9,135,538)	$ (9,225,169)	$ (9,135,538)